Valence ロゴ
人気
ログイン
Loading data for BFRIW — first visit, this takes a few seconds.

ウォッチリストに追加

Biofrontera Inc.

NasdaqCM: BFRIW · リアルタイム株価 · USD
0.03
+0.00 (0.00%)
終値時点： Aug 25, 2026, 2:52 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Biofrontera Inc.（BFRIW）の株価・分析・データ

0.00%
買気配n/a
時価総額n/a
売上高（TTM）46.17M
純利益（TTM）-6.37M
0.80
-1.3
n/a
n/a
PBR（TTM）0.07
PSR（TTM）n/a
決算発表日n/a
売気配n/a
出来高156
平均出来高（20日）
始値0.10
前日終値0.03
当日レンジ0.03 - 0.03
52週レンジ0.03 - 0.03
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

BFRIWについて

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts....

[続きを読む]
業種
セクター
IPO日 Jul 17, 2026
従業員数 84
上場取引所 NasdaqCM
ティッカー BFRIW
ウェブサイト https://www.biofrontera-us.com
企業情報の全文

業績

2025年のBiofronteraの売上高は41.7Mで、前年の37.32Mから11.75%の増加でした。 利益は-10.54Mで、-40.67%の減少でした。

財務諸表
news image

6日前 · Motley Fool

Biofrontera (BFRI) Q2 2026 Earnings Call Transcript

Gross margins expanded 920 basis points as restructured costs offset ITC lamp restrictions.

news image

1週間前 · Moby

Biofrontera Inc. Q2 2026 Earnings Call Summary

Moby summary of Biofrontera Inc.'s Q2 2026 earnings call

news image

1週間前 · GuruFocus.com

Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ...

Biofrontera Inc (BFRI) reports a 45% jump in Ameluz prescriptions and improved gross margins, while navigating competitive pressures and a widened net loss in Q2 2026.

news image

1週間前 · Zacks

Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of +70.59% and +33.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

2か月前 · Motley Fool

Biofrontera (BFRI) Q1 2026 Earnings Transcript

All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings, including the company's quarterly report on Form 1...

2ページ中1ページ